Ipsilateral breast cancer recurrence

Breast

Volumn 17, Issue 1, 2008, Pages 12.e1-12.e13

  Benson, John R ^a   Querci della Rovere, G ^b  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

Breast conserving surgery; Distant metastases; Local recurrence; Survival

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; AROMATASE INHIBITOR; TAMOXIFEN;

ADJUVANT THERAPY; ARTICLE; AXILLARY LYMPH NODE; BRACHYTHERAPY; BREAST CANCER; BREAST SURGERY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RELAPSE; CANCER SURVIVAL; CLINICAL PRACTICE; CLINICAL TRIAL; DISEASE FREE SURVIVAL; HUMAN; INTENSITY MODULATED RADIATION THERAPY; IRELAND; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MASTECTOMY; MEDICAL DECISION MAKING; METASTASIS POTENTIAL; OVERALL SURVIVAL; PARTIAL MASTECTOMY; PATIENT ATTITUDE; PRIORITY JOURNAL; PROGNOSIS; PSYCHOLOGICAL ASPECT; SENTINEL LYMPH NODE BIOPSY; SPAIN; SURGICAL TECHNIQUE; TREATMENT OUTCOME; UNITED KINGDOM;

EID: 39149122154     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.breast.2007.06.006     Document Type: Article

References (32)

1. Fisher B., Anderson S., Fisher E.R., et al. Significance of ipsilateral breast tumour recurrence after lumpectomy. Lancet 338 (1991) 327-331
2. Veronesi U., Marubini E., Del Vecchio M., et al. Local recurrences and distant metastases after conservative breast cancer treatments: partly independent events. J Natl Cancer Inst 87 (1995) 19-27
3. Komoike Y., Akiyama F., Lino Y., et al. Ipsilateral breast tumour recurrence (IBTR) after breast conserving treatment for breast cancer. Cancer 106 (2005) 35-39
4. Wapnir I.L., Anderson S.J., Mamounas E.P., et al. Prognosis after ipsilateral breast tumour recurrence and locoregional recurrences in five national surgical adjuvant breast and bowel project randomized clinical trials. J Clin Oncol 24 (2006) 2028-2036
5. Early Breast Cancer Trialists Collaborative Group (EBCTCG). Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15 year survival: an overview of the randomized trials. Lancet 366 (2005) 2087-2106
6. Benson J.R., Querci della Rovere G., and TLO. The biological significance of ipsilateral local recurrence of breast cancer: determinant or indicator of poor prognosis. Lancet Oncol 3 (2002) 45-49
7. Paik S., Shak S., Tang G., et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. NEJM 351 (2004) 2817-2826
8. Halsted W.S. The results of radical operations for the cure of cancer of the breast performed at the Johns Hopkins Hospital from June 1889 to January 1894. Ann Surg 20 (1898) 455-497
9. Fisher B. Laboratory and clinical research in breast cancer-a personal adventure. The David A. Karnofsky memorial lecture. Cancer Res 40 (1980) 3863-3874
10. Overgaard M., Hansen P.S., Overgaard J., et al. Post-operative radiotherapy in high risk pre-menopausal women with breast cancer who receive adjuvant chemotherapy. N Eng J Med 337 (1997) 949-955
11. Ragaz J., Jackson S.M., Le N., et al. Adjuvant radiotherapy and chemotherapy in node positive pre-menopausal women with breast cancer. N Eng J Med 337 (1997) 956-962
12. Van Tienhoven G., Voogd A.C., Peterse J.L., et al. Prognosis after treatment for loco-regional recurrence after mastectomy or breast conserving therapy in two randomized trials (EORTC and DBCG-82TM). Eur J Cancer 35 (1999) 32-38
13. Demicheli R., Valugussa P., and Bonadonna G. Double-peaked time distribution of mortality for breast cancer patients undergoing mastectomy. Breast Cancer Res Treat 75 (2002) 127-134
14. Fortin A., Larochelle M., Laverdiere J., et al. Local failure is responsible for the decrease in survival for patients with breast cancer treated with conservative surgery and post-operative radiotherapy. J Clin Oncol 101 (1999) 104-109
15. Baum M., Demicheli R., Hrushesky W., Retsky M., et al. Does surgery unfavourably perturb the "natural history" of early breast cancer by accelerating the appearance of distant metastases. Eur J Cancer 41 (2005) 508-515
16. Saphner T., Tormey D.C., Gray R., et al. Annual hazard rates of recurrence for breast cancer after primary therapy. J Clin Oncol 14 (1996) 2738-2746
17. A Howell (on behalf of the ATAC Trialists Group). ATAC trial update. Lancet 365 (2005) 1225-1226
18. Millis R., Barnes D., Lampejo O.T., et al. Tumour grade does not change between primary and recurrent mammary carcinoma. Eur J Cancer 34 (1998) 548-553
19. Tsutsui S., Ohno S., Murakami S., et al. Flow cytometric analysis of DNA ploidy in primary, metastatic and recurrent breast cancers. Oncol Rep 9 (2002) 793-799
20. Regitnig P., Moser R., Thalhammer M., et al. Microsatellite analysis of breast carcinoma and corresponding local recurrences. J Pathol 198 (2002) 190-197
21. Waldman F.M., DeVries S., Chew K.L., et al. Chromosomal alterations in ductal carcinomas in situ and their in situ recurrences. J Natl Cancer Inst 92 (2000) 313-320
22. Golledge, Wiggins J.E., and Callam M. Effect of surgical subspecialisation on breast cancer outcome. Br J Surg (2000) 1420-1425
23. Naik A.M., Fey J., Gemignani M., et al. The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a follow up study of 4008 procedures. Ann Surg 240 (2004) 462-468
24. Veronesi U., Paganelli G., Viale G., et al. A randomized comparison of sentinel node biopsy with routine axillary dissection in breast cancer. N Eng J Med 349 (2003) 546-553
25. McDermott E.W. Irish guidelines for surgeons in the management of breast cancer. Ir Med J 90 (1997) 6-10
26. Taghian A., Mohiuddin M., Jagsi R., et al. Current perceptions regarding surgical margin status after breast conserving therapy. Ann Surg 241 (2005) 629-639
27. Goss P.E., Ingle J.N., Martino S., et al. Randomised trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: Updated findings from NCIC CTG MA.17. J Natl Cancer Inst 97 (2005) 1262-1271
28. Cheng S.H., Horng C.F., West M., et al. Genomic prediction of loco-regional recurrence after mastectomy in breast cancer. J Clin Oncol 24 (2006) 4594
29. Hanrahan E.O., Broglio K.R., Buzdar A.U., et al. Combined-modality treatment for isolated recurrences of breast carcinoma: update on 30 years of experience at the University of Texas MD Anderson cancer center and assessment of prognostic factors. Cancer 104 (2005) 1158-1171
30. David Sylvester A. The brutality of fact (1988), Thames and Hudson
31. Correspondence: Effects of radiotherapy for surgery and of surgery for early breast cancer. Lancet 2006; 367: 1652-55.
32. Evans I., Thornton H., and Chalmers I. Testing treatments: better research for better healthcare (2005), British Library Chapter 2